Skip to main content
. 2023 Aug 26;11(24):5643–5652. doi: 10.12998/wjcc.v11.i24.5643

Table 3.

Multivariate analysis of progression-free survival

Prognostic factor
HR (95%CI)
P value
Age 1.059 (1.033-1.085) ≤ 0.001
ISS stage 2.136 (1.500-3.041) ≤ 0.001
DS stage 1.622 (0.264-1.622) 0.264
GPT 1.017 (0.997-1.036) 0.097
GOT 1.002 (0.977-1.028) 0.857
LDH 1.000 (0.997-1.003) 0.944
Platelet count 1.880 (0.732-4.830) 0.189
Maintenance regimen 0.410 (0.236-0.710) 0.001
Autotransplantation 0.201 (0.069-0.583) 0.003
TC 0.689 (0.533-0.891) 0.005
C1 reduction rate 0.474 (0.293-0.767) 0.002
C2 reduction rate 0.792 (0.440-1.427) 0.438
C3 reduction rate 1.974 (0.921-4.230) 0.08
C4 reduction rate 0.254 (0.139-0.463) ≤ 0.001

HR: Hazard ratio; 95%CI: 95% confidence interval; ISS: International Staging System; DS: Durie-Salmon; GPT: Glutamic-pyruvic transaminase; GOT: Glutamic-oxaloacetic transaminase; LDH: Lactate dehydrogenase; TC: Total cholesterol; C1: The first cycle; C2: The second cycle; C3: The third cycle; C4: The fourth cycle.